A cross sectional study to determine the prevalence and risk factors of non alcoholic fatty liver diseases among diabetics I and II

Geetha Navuduri; Asma .

doi:10.18203/2349-3933.ijam20200081

Authors

Geetha Navuduri Department of General Medicine, Gandhi Medical College, Hyderabad, Telangana, India
Asma . Department of Community Medicine, Government Medical College, Mahabubnagar, Hyderabad, Telangana, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20200081

Keywords:

Body mass index, Diabetes mellitus, Non-alcoholic fatty liver disease, Triglycerides and cholesterol, Waist hip ratio

Abstract

Background: Non Alcoholic Fatty Liver Disease (NAFLD) is an important health problem globally as well as in India. The present was taken to determine the prevalence of NAFLD among diabetics attending a tertiary care hospital in Telangana.

Methods: A total of 75 subjects who were all diabetics were taken. The diagnosis of NAFLD was done using Ultra sonogram. Preliminary information along with duration of diabetes, Waist Hip Ratio, Body Mass Index, Triglycerides and Cholesterol was collected and analyzed.

Results: The prevalence of NAFLD among diabetics was 41.3%. Majority of the subjects belonged to age group of 41-60 years. The prevalence of NAFLD among females was 35.99%. Among patients who had Non-alcoholic fatty liver disease 74.19% had Waist Hip ratio >1. Almost 90.3% had higher levels of triglycerides (>180 mg/dl).

Conclusions: The prevalence of NAFLD among diabetics was comparatively high. Early diagnosis, treatment, awareness and education is needed to reduce the burden of NAFLD.

Metrics

Metrics Loading ...

References

Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Pal A, et al. Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India. Diabe Metab Synd. 2017 Dec;9(1):8.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Aust Med J. 2014;7(1):45-8.

K Park. Parks textbook of Social and Preventive medicine. 24th ed. India: Bhanot Publishers; 2015: 410-415.

Stephaine Watson. Everything you need to know about diabetes. Health line. Published on 4th Oct 2018. Available at: https://www.healthline.com/health/diabetes. Accessed 17 December 2019.

James Roland. “Non-Alcoholic Fatty Liver Disease”. Health Line. Published on 28th Feb 2019. Available at: https://www.healthline.com/health/nonalcoholic-fatty-liver-disease. Accessed 17 December 2019.

Rinella Mt, Sanyal AJ. Management of Non Fatty Alcoholic Liver Disease: A style based approach. Nature reviews. Gastroenterol Hepatol. 20196;13(4):196-205.

Kalra S, Vithalani M, Gulati G, Kulkarni CM, Kadam Y, Pallivathukkal J, et al. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT). J Assoc Phys Ind. 2013 Jul;61(7):448-53.

Majumdar A, Misra P, Sharma S, Kant S, Krishnan A, Pandav CS. Prevalence of non-alcoholic fatty liver diseases in adult population in a rural community of Haryana. Ind J Pub Health. 2016;60(1):26-33.

Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni C1. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabe Res Clini Pract. 2009 Apr 1;84(1):84-91.

Dassanayake AS, Kasturiratne A, Rajindrajith S, Kalubowila U, Chakrawarti S, De Silva AP, et al. Prevalence and risk factors of non-alcoholic fatty liver diseases among adults in an urban Sri Lankan population. J Gastro Hepatol. 2009 Jul;24(7):1284-8.

Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, et al. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Ind J Med Res. 2009 Mar 1;129(3):285-92.

Ahad Eshraghian MD, Eshraghian MDH, Omrani MD GR. Nonalcoholic fatty liver disease in a cluster of Iranian popula-tion: thyroid status and metabolic risk factors. Arch Iranian Med. 2013 Oct;16(10):584-9.

Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatol. 2010 May;51(5):1593-602.

Rao RB, Khan SA, Suleman D, Ahmed A, Lakshmi GJ, Lakshminarayan V. Study of lipid profile in non-alcoholic fatty liver diseases. J Dental Med Sci. 2017;16(11)46-9.

Fan N, Peng L, Xia Z, Zhang L, Song Z, Wang Y, et al. Triglycerides to high-density lipoprotein cholesterol ratio as a surrogate for nonalcoholic fatty liver disease: a cross-sectional study. Lipids Health Dis. 2019 Dec;18(1):39.

Musso G, Gambhino R, Casseder M. Cholesterol metabolism and the pathogenesis of non-alcoholic fatty liver diseases. Prog Lipid Res. 2013 Jan;52(1):175-91.

Enjoji M, Nakamuta M. Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease?. World J Gastroenterol: WJG. 2010 Feb 21;16(7):800-03.